Debiopharm
Debiopharm is a biopharmaceutical company focused on developing therapies for cancer and infectious diseases. They are developing Debio 1453, a novel antibiotic with a new mechanism of action to treat _Neisseria gonorrhoeae_ infections. This approach offers a crucial treatment alternative against multi-drug-resistant infections.
Funding Round: Grant
Funding Amount: $12.3M
Date: 28-May-2025
Investors: CARB-X
Markets: Biotech, Pharmaceuticals, Healthcare
HQ: Lausanne, Switzerland
Founded: 1979
Website: http://www.debiopharm.com
LinkedIn: https://www.linkedin.com/company/debiopharminternational/
Facebook: http://www.facebook.com/pages/Debiopharm-Group
Crunchbase: https://www.crunchbase.com/organization/debiopharm
Leave a Comment
Comments
No comments yet.